Filter by:
Paul Pfeiffer, MD, MS
Susan Crumpacker Brown Research Professor of Depression
Department of Psychiatry
Michigan Medicine
This webinar will review the major psychotropic medication classes, including antidepressants, benzodiazepines, hypnotics, other antianxiety, stimulants, mood stabilizers, and antipsychotics. Behavioral Health Care Managers will learn the indication, risks, and common side effects of each class and considerations for special populations.
This webinar will address the physical and neurological signs and symptoms of eating disorders, ranging from positive findings on review of symptoms to common psychiatric and neurocognitive manifestations of excess energy intake, dietary restriction or weight loss, and purging. We will review Society of Adolescent Health and Medicine criteria for assessing malnutrition and options for management of physical and psychiatric complications.
Vishvanie Bernadene (Bernie) Stoody, MD, MSc
University of Michigan Medical School Department of Pediatrics, Division of Adolescent Medicine
This webinar will guide clinicians in how to implement screening for suicidal ideation within the pediatric primary care setting. Specifically, it will explore the unique challenges facing this population and cultivate how to effectively use protective factors to create robust safety strategies.
Katherine Riley, LMSW
Bronson Healthcare Group
Hailey Santana, LMSW
Bronson Healthcare Group
Donovan Maust, MD
Associate Professor
Michigan Medicine
VA Ann Arbor Healthcare System
Sarah Vordenberg, PharmD, MPH
Clinical Associate Professor Associate Chair, Department of Clinical Pharmacy
University of Michigan College of Pharmacy
This webinar, A Rational Approach to Prescribing and Deprescribing Benzodiazepines, will discuss the importance of deprescribing, especially for older adults. We will specifically focus on promoting safe benzodiazepine prescribing practices for this population. By the end of this webinar participants will be able to apply the latest risk/benefit evidence to:
- Discuss the epidemiology of benzodiazepine prescribing and latest risk/benefit evidence
- Describe why deprescribing may be an important intervention for many older adults
- Review what benzodiazepine deprescribing entails
Iman Saleem, MPH
Adolescent Health Initiative
This is a webinar designed to empower parents in actively participating in their youth's healthcare journey. This session will provide valuable insights and practical strategies to help you become an effective advocate for your youth's health needs.
Jonathan Morrow, MD, PhD Associate Professor
Department of Psychiatry
Michigan Medicine
This webinar aims to help primary care physicians, behavioral health care managers, and other primary care practice team members identify and address stigmatizing behaviors among themselves and colleagues when treating patients with substance use disorders.
Teague Simoncic, LMSW, PCM-H
Grove Emotional Health Collaborative
Developing a Postpartum Mood and Anxiety Disorder (PMAD) is the most common complication of childbirth, impacting around 20% of birthing people. Unfortunately, PMADs are underdiagnosed and undertreated, which has a lasting impact on parents and their children. In this presentation, participants will learn the difference between PMADs and "baby blues," how to identify common symptoms of PMADs as they present in primary care, common risk factors for developing PMADs, and how to thoughtfully speak about PMADs and their impact. In addition, participants will receive information about effective, evidence-based screenings and interventions to use when working with patients with PMADs.
Liz Williams, M.Ed.
Michigan State University Extension
Dawn Contreras, Ph.D.
Michigan State University Extension
Participants in this webinar will learn about the importance of sleep for good physical and mental health and key strategies for improving sleep quality and quantity. They will also gain increased awareness of a free evidence-based sleep education program (SLEEP) and ways to refer patients to that program.